1st Quarter - Report — SOCIETY FOR CARDIOVASCULAR ANGIOGRAPHY… for SOCIETY FOR CARDIOVASCULAR ANGIOGRAPHY… (2016)

Firm

SOCIETY FOR CARDIOVASCULAR ANGIOGRAPHY AND INTERVENTIONS

Client

SOCIETY FOR CARDIOVASCULAR ANGIOGRAPHY AND INTERVENTIONS

Income

—

Expenses

$30,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

FDA Device Review Process etc

Lobbyist	Covered position, as disclosed
WAYNE ALAN POWELL	—

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS)

Health Issues HCR

Medicare PPACA Reform FDA Reform

Lobbyist	Covered position, as disclosed
WAYNE ALAN POWELL	—

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS)

Medicare/Medicaid MMM

Coverage and Payment for Physician Services

Lobbyist	Covered position, as disclosed
WAYNE ALAN POWELL	—

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE; Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.